GXFC3 (Combivir 150 mg / 300 mg)

Generic Name: lamivudine/zidovudine

Pill imprint GXFC3 has been identified as Combivir 150 mg / 300 mg.

Combivir is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GXFC3

Combivir 150 mg / 300 mg GXFC3  Front
Combivir 150 mg / 300 mg GXFC3  Back
Combivir 150 mg / 300 mg GXFC3
Combivir 150 mg / 300 mg GXFC3
Combivir
Generic Name:
lamivudine/zidovudine
Imprint:
GXFC3
Strength:
150 mg / 300 mg
Color:
White
Size:
17.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0595
Inactive Ingredients:
silicon dioxide colloidal
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)